![Mark A. Asbury](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark A. Asbury
No open positions remaining
Profile
Mark A. Asbury worked as a Senior Director-Transactional Law at Genentech, Inc. from 1996 to 2011.
He then worked as Vice President & General Counsel at Pharmacyclics LLC.
In 2014, he became the Chief Legal Officer at ZS Pharma, Inc. and in 2015, he was promoted to that company's General Counsel.
From 2016 to 2017, he worked as General Counsel at Samsara Biocapital LLC.
In 2018, he became the Chief Legal Officer & General Counsel at Allakos, Inc. Mr. Asbury received his undergraduate degree from Vanderbilt University and his graduate degree from Stanford Law School.
Former positions of Mark A. Asbury
| Companies | Position | End |
|---|---|---|
| ALLAKOS INC. | General Counsel | 19/04/2022 |
Samsara Biocapital LLC
 Samsara Biocapital LLC Investment ManagersFinance Samsara BioCapital invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and pharmaceuticals. It provides early and later stage capital requirements. | General Counsel | 01/01/2017 |
| ZS PHARMA INC | General Counsel | 01/01/2016 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | General Counsel | 01/06/2011 |
| PHARMACYCLICS, INC. | General Counsel | - |
Training of Mark A. Asbury
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
87
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
ZS Pharma, Inc.
 ZS Pharma, Inc. BiotechnologyHealth Technology Develops develop new treatments of kidney and liver diseases | Health Technology |
Vanderbilt University
 Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Allakos, Inc.
 Allakos, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company that develops innovative therapeutics which target immunomodulatory receptors for the treatment of allergic, inflammatory and proliferative diseases | Health Technology |
Stanford Law School
 Stanford Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Samsara Biocapital LLC
Samsara Biocapital LLC Investment ManagersFinance Samsara BioCapital invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and pharmaceuticals. It provides early and later stage capital requirements. | Finance |
- Stock Market
- Insiders
- Mark A. Asbury
